Tuesday, July 21, 2026

6:00 – 6:30 p.m. PT | Registration & dinner
6:30 – 8:00 p.m. PT | CME presentation & dessert

Marina del Rey Marriott
4100 Admiralty Way
Marina del Rey, CA 90292
Meeting room: Bayview Ballroom

PROGRAM FEATURES

• 1.5 CME & CNE Credit
• Interactive case-based discussion
• Real patient cases from the Day in the Life docuseries
• Whiteboard animations
• A variety of point-of-care tools & resources
• Patient advocacy resource station

FACULTY

	Paras Karmacharya, MD, MS Assistant Professor of Medicine Division of Rheumatology and Immunology Director, Vanderbilt Psoriatic Arthritis and Spondyloarthritis Center Vanderbilt University Medical Center Nashville, Tennessee
	Veena K. Ranganath, MD, MS Associate Clinical Professor Department of Medicine, Division of Rheumatology Co-Director, Masters of Science in Clinical Research Program (MSCR) Director, Rheumatology Fellowship Musculoskeletal Ultrasound Training University of California Los Angeles, California

PROGRAM OVERVIEW

This rheumatology-focused CME summit uses interactive, case-based learning to illuminate the shared inflammatory messengers that connect obesity with psoriatic arthritis (PsA) and contribute to both musculoskeletal and systemic pathology. Faculty will guide participants in applying current obesity treatment guideline recommendations and supporting evidence to real-world PsA cases involving patients with excess body weight. Through collaborative discussion and multidisciplinary problem solving, attendees will explore practical strategies to build and sustain coordinated care teams that optimize outcomes for patients managing both PsA and obesity.

TARGET AUDIENCE

This educational activity is intended to educate rheumatologists, gastroenterologists, dermatologists, and related advanced practice providers in the care of patients with obesity and IMIDs.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Describe the immune messengers common to both obesity and IMIDs and their resultant corresponding pathologies
• Incorporate obesity treatment guideline recommendations and their supporting data into the management of patients with both IMIDs and excess body weight
• Develop and maintain a collaborative multidisciplinary team to optimize care for the patient with IMIDs and obesity

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this live activity for a maximum of 1.5 ANCC contact hours.

ACCME INNOVATION PARTNER - US Learners Only

Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.

PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]